Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling

Oncogene

Volumn 29, Issue 31, 2010, Pages 4388-4398

  Lyngaa, R ^a   Norregaard K ^b   Kristensen, M ^a   Kubale, V ^b   Rosenkilde, M M ^b   Kledal, T N ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cell transformation; constitutive activity; Epstein Barr virus; G protein coupled receptor; signaling; VEGF

Indexed keywords

BILF1 PROTEIN; G PROTEIN COUPLED RECEPTOR; MUTANT PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL GROWTH; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; KAPOSI SARCOMA; MOUSE; NONHUMAN; NUDE MOUSE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VIRAL PROTEINS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4; MUS MUSCULUS;

EID: 77955472290     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.173     Document Type: Article

References (47)

1. Arvanitakis L, Geras-Raaka E, Varma A, Gershengorn MC, Cesarman E. (1997). Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385: 347-350.
2. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS et al. (1998). G-protein-coupled receptor of Kaposi's sarcomaassociated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86-89.
3. Beisser PS, Grauls G, Bruggeman CA, Vink C. (1999). Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. J Virol 73: 7218-7230.
4. Beisser PS, Verzijl D, Gruijthuijsen YK, Beuken E, Smit MJ, Leurs R et al. (2005). The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNAdependent protein kinase. J Virol 79: 441-449.
5. Bodaghi B, Jones TR, Zipeto D, Vita C, Sun L, Laurent L et al. (1998). Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus- infected cells. J Exp Med 188: 855-866.
6. Burger M, Burger JA, Hoch RC, Oades Z, Takamori H, Schraufstatter IU. (1999). Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor. J Immunol 163: 2017-2022.
7. Cesarman E, Mesri EA, Gershengorn MC. (2000). Viral G proteincoupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? J Exp Med 191: 417-422.
8. Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD, Barrell BG et al. (1997). Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. J Virol 71: 1521-1529.
9. Geras-Raaka E, Varma A, Clark-Lewis I, Gershengorn MC. (1998a). Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor. Biochem Biophys Res Commun 253: 725-727. (Pubitemid 29039209)
10. Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, Gershengorn MC. (1998b). Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 188: 405-408. (Pubitemid 28357769)
11. Greulich H, Chen TH, Feng W, Janne PA, Alvarez JV, Zappaterra M et al. (2005). Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants. PLoS Med 2: e313.
12. Ho HH, Ganeshalingam N, Rosenhouse-Dantsker A, Osman R, Gershengorn MC. (2001). Charged residues at the intracellular boundary of transmembrane helices 2 and 3 independently affect constitutive activity of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Biol Chem 276: 1376-1382.
13. Hong GK, Gulley ML, Feng WH, Delecluse HJ, Holley-Guthrie E, Kenney SC. (2005a). Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol 79: 13993-14003.
14. Hong GK, Kumar P, Wang L, Damania B, Gulley ML, Delecluse HJ et al. (2005b). Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J Virol 79: 13984-13992.
15. Kieff ED, Rickinson AB. (2007). Epstein-Barr virus and its replication. In: Knipe DM, Howley PM (eds). Fields Virology. Lippencott Williams & Wilkins: Philadelphia, pp 2603-2654.
16. Kledal TN, Rosenkilde MM, Schwartz TW. (1998). Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. FEBS Lett 441: 209-214.
17. Krishna SM, James S, Balaram P. (2006). Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status. Virus Res 115: 85-90.
18. Maussang D, Verzijl D, van WM, Leurs R, Holl J, Pleskoff O et al. (2006). Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci USA 103: 13068-13073.
19. McLean KA, Holst PJ, Martini L, Schwartz TW, Rosenkilde MM. (2004). Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. Virology 325: 241-251.
20. Mirzadegan T, Benko G, Filipek S, Palczewski K. (2003). Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42: 2759-2767.
21. Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y et al. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23-36.
22. Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE. (1996). Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 9: 621-630.
23. Murono S, Inoue H, Tanabe T, Joab I, Yoshizaki T, Furukawa M et al. (2001). Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells. Proc Natl Acad Sci USA 98: 6905-6910.
24. O'Neil JD, Owen TJ, Wood VH, Date KL, Valentine R, Chukwuma MB et al. (2008). Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J Gen Virol 89: 2833-2842.
25. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS. (1991). Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337: 320-322.
26. Pati S, Cavrois M, Guo HG, Foulke Jr JS, Kim J, Feldman RA et al. (2001). Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75: 8660-8673.
27. Paulsen SJ, Rosenkilde MM, Eugen-Olsen J, Kledal TN. (2005). Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J Virol 79: 536-546.
28. Paydas S, Ergin M, Erdogan S, Seydaoglu G. (2008). Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas. Leuk Res 32: 1424-1430.
29. Pleskoff O, Casarosa P, Verneuil L, Ainoun F, Beisser P, Smit M et al. (2005). The human cytomegalovirus-encoded chemokine receptor US28 induces caspase-dependent apoptosis. FEBS J 272: 4163-4177.
30. Rajagopal K, Lefkowitz RJ, Rockman HA. (2005). When 7 transmembrane receptors are not G protein-coupled receptors. J Clin Invest 115: 2971-2974.
31. Rosenkilde MM, Kledal TN. (2006). Targeting herpesvirus reliance of the chemokine system. Curr Drug Targets 7: 103-118.
32. Rosenkilde MM, Kledal TN, Brauner-Osborne H, Schwartz TW. (1999). Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74. J Biol Chem 274: 956-961.
33. Rosenkilde MM, Kledal TN, Schwartz TW. (2005). High constitutive activity of a virus-encoded seven transmembrane receptor in the absence of the conserved DRY motif (Asp-Arg-Tyr) in transmembrane helix 3. Mol Pharmacol 68: 11-19.
34. Rosenkilde MM, ned-Jensen T, Andersen H, Holst PJ, Kledal TN, Luttichau HR et al. (2006). Molecular pharmacological phenotyping of EBI2. An orphan seven-transmembrane receptor with constitutive activity. J Biol Chem 281: 13199-13208.
35. Rosenkilde MM, Smit MJ, Waldhoer M. (2008). Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors. Br J Pharmacol 153(Suppl 1): S154-S166.
36. Schwarz M, Murphy PM. (2001). Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J Immunol 167: 505-513.
37. Sheng W, Decaussin G, Ligout A, Takada K, Ooka T. (2003). Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol 77: 3859-3865.
38. Smit MJ, Verzijl D, Casarosa P, Navis M, Timmerman H, Leurs R. (2002). Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor ORF74 constitutively activates p44/p42 MAPK and Akt via G(i) and phospholipase C-dependent signaling pathways. J Virol 76: 1744-1752.
39. Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA et al. (2000). The Kaposi's sarcoma-associated herpes virus G proteincoupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60: 4873-4880.
40. Streblow DN, Vomaske J, Smith P, Melnychuk R, Hall L, Pancheva D et al. (2003). Human cytomegalovirus chemokine receptor US28-induced smooth muscle cell migration is mediated by focal adhesion kinase and Src. J Biol Chem 278: 50456-50465.
41. Vieira J, Schall TJ, Corey L, Geballe AP. (1998). Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Virol 72: 8158-8165.
42. Vischer HF, Nijmeijer S, Smit MJ, Leurs R. (2008). Viral hijacking of human receptors through heterodimerization. Biochem Biophys Res Commun 377: 93-97.
43. Waldhoer M, Kledal TN, Farrell H, Schwartz TW. (2002). Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. J Virol 76: 8161-8168.
44. Walling DM, Flaitz CM, Nichols CM. (2003). Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 188: 883-890.
45. Xue SA, Labrecque LG, Lu QL, Ong SK, Lampert IA, Kazembe P et al. (2002). Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi. Int J Cancer 99: 635-643.
46. Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M et al. (2000). Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191: 445-454.
47. Zuo J, Currin A, Griffin BD, Shannon-Lowe C, Thomas WA, Ressing ME et al. (2009). The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog 5: e1000255. 4436-4448